Public Inquiry

Infected Blood Inquiry

Status: Completed Chair: Sir Brian Langstaff Established: Sep 2018 Report: May 2024 Commissioned by: Cabinet Office

Examining how thousands of NHS patients were infected with HIV and Hepatitis C through contaminated blood products in the 1970s and 1980s. Found the scandal could largely have been avoided and victims were failed by the NHS, government, and blood …

Response breakdown

103 recommendations total

72%

27%

74 (72%) — Accepted

28 (27%) — Accepted in Part

1 (1%) — Under Review

Reports & milestones

Reports

09 Jul 2025 26 tracked recs Additional Report on Compensation · Tracked recommendations · PDF

20 May 2024 58 tracked recs Infected Blood Inquiry Final Report · Tracked recommendations · PDF

29 Jul 2022 1 tracked rec First Interim Report · Tracked recommendations · PDF

05 Apr 2023 18 tracked recs Second Interim Report · Tracked recommendations · PDF

Timeline

11 Jul 2017 Inquiry Announced Prime Minister Theresa May announced a public inquiry. · Source

11 Jul 2017 Chair Appointed Sir Brian Langstaff appointed as Chair.

25 Jul 2018 Terms of Referenc… Terms of Reference published. · Source

30 Apr 2019 Hearings Begin Public hearings commenced.

19 Jul 2022 First Interim Rep… Interim report on compensation framework. · Source

05 Apr 2023 Second Interim Re… Second interim report with further compensation recommendations.

20 May 2024 Final Report Publ… Final report published finding decades of cover-up. · Source

21 May 2024 Government Apology Prime Minister issued full apology in Parliament. · Source

Recommendations

26 shown (filtered)

Code	Recommendation	Addressed to	Response
AC-1a	Open Registration The scheme be opened to registration to everyone who may be eligible.	IBCA	Accepted	View →
AC-1b	Registration and Application Forms There be forms (devised by IBCA) for people to register and apply for a core award and the supplementary awards with/without the …	IBCA	Accepted	View →
AC-1c	Legal Support Signposting IBCA include a prominent reference to the availability of legal support paid by IBCA on all registration and application forms and in …	IBCA	Accepted	View →
AC-1d	Three-Cohort Prioritisation When IBCA opens up the service beyond people infected and registered with the support schemes, IBCA: (i) update the sequencing to three …	IBCA	Accepted	View →
AC-1e	Oral Representations at Review IBCA consider making provision, either generally or in specific cases, for oral representations to be made where a decision is reviewed internally, …	IBCA	Accepted	View →
AC-1f	Written Reasons for Decisions Written reasons for the original decision must be provided so that the review process can operate fairly.	IBCA	Accepted	View →
AC-2a	Publish Guidance and Board Minutes IBCA should publish: guidance, advice or instructions to claim managers; work undertaken by IBCA with the Cabinet Office's policy team to ensure …	IBCA	Accepted	View →
AC-2b	Share Clinical Assessor Advice In respect of any case in which the advice of a clinical assessor has been given, in relation to the person concerned …	IBCA	Accepted	View →
AC-2c	Community Advisory Body A formal role be given within IBCA for an advisory body consisting of people infected and affected, covering a range of experience …	IBCA	Accepted	View →
AC-2d	Structured Response to Community Input To build confidence that IBCA is actively listening to people infected and affected, IBCA adopt more of a structured response to contributions …	IBCA	Accepted	View →
IBI-A-2e	Transparency of Scheme Design The Government and IBCA establish a mechanism by which individuals or organisations may raise concerns which arise about any aspect of the …	UK Government	Accepted	View →
IBI-A-3a	HIV Eligibility Start Date An amendment to the Regulations be made as soon as possible to remove the reference to 1 January 1982 from Regulation 3.	UK Government	Accepted	View →
IBI-A-4a	Interferon Treatment Impacts People infected with Hepatitis B or C who have received a course of treatment with or based on interferon should be recognised …	UK Government	Accepted in Part	View →
IBI-A-4b	Special Category Mechanism The Government reconsider whether to maintain its rejection in February 2025 of the recommendations of Sir Robert Francis KC and advice from …	UK Government	Accepted in Part	View →
IBI-A-4c	Effective Treatment - Earnings Floor For the calculation of Financial Loss awards for Hepatitis B, people born after 1953 should be treated like those born in or …	UK Government	Accepted	View →
IBI-A-4d	Deeming of Severity Bands Where the level of severity of a person's infection at Level 3 or more has been established to IBCA's satisfaction in relation …	UK Government	Accepted	View →
IBI-A-4e	Evidence of Diagnosis Date Regulation 14(2)(c) be amended to remove the requirement for evidence of the date of diagnosis of Hepatitis B or C. An appropriate …	UK Government	Accepted	View →
IBI-A-5a	Severe Psychological Harm The approach of the Infected Blood Psychology Service is adopted so that both a diagnosis made by a psychiatric professional and a …	UK Government	Accepted in Part	View →
IBI-A-6a	Financial Loss and Care "x" be removed from the equation set out in Regulation 7.	UK Government	Accepted in Part	View →
IBI-A-6b	Exceptional Loss Evidence The Cabinet Office consult on whether the evidential requirements for exceptional reduced earnings are likely to prove a barrier to people who …	UK Government	Accepted in Part	View →
IBI-A-7a	Unethical Research Award Where there is evidence that an individual was the victim of unethical research practices IBCA should be authorised to make an unethical …	UK Government	Accepted in Part	View →
IBI-A-7b	Wider Definition of Unethical Research When considering the evidence IBCA applies the wider definition of research explained in the Infected Blood Inquiry Additional Report chapter on Unethical …	UK Government	Accepted in Part	View →
IBI-A-7c	Unethical Research Award Amount Review The Minister consider whether the £10,000 (£15,000 for Treloar's pupils) should in justice be increased and further decides what sum he considers …	UK Government	Under Consideration	View →
IBI-A-8a	Supplementary Route for Affected Persons The Minister give consideration to there being a supplementary route for people affected. This could include opening the supplemental award for severe …	UK Government	Accepted in Part	View →
IBI-A-8b	Affected Estates The Regulations be amended such that where someone who would be an eligible affected person dies between 21 May 2024 and 31 …	UK Government	Accepted	View →
IBI-A-9a	Bereaved Partner Support Scheme The IBSS cut-off date of 31 March 2025 be reviewed, that the scheme should as soon as possible reinstate support payments to …	UK Government	Accepted	View →

Parliamentary activity

386 mentions since Sep 2017

52 debates 284 questions 45 statements

15 Jun 2026 Early Day Motion Infected Blood Inquiry compensation
Lisa Smart (Liberal Democrat)

19 May 2026 Written Question Infected Blood Inquiry: Costs
Mike Wood (Conservative)

13 May 2026 Early Day Motion Redress for people impacted by surgical mesh, sodium valproate and Primodos
Sarah Green (Liberal Democrat)

14 Apr 2026 Written Ministerial Statement Update on the Infected Blood Compensation Scheme
Baroness Anderson of Stoke-on-Trent (Labour)

14 Apr 2026 Written Ministerial Statement Update on the Infected Blood Compensation Scheme
Nick Thomas-Symonds (Labour)

View all 386 mentions →

Costs

Total: £146,162,778

Period	Total	Inquiry legal	CP legal	Source
Mar 2025 (cum.)	£146,162,778	£67,290,993	£27,242,761	link
Mar 2025	£5,511,059	£1,514,906	£603,277	link
Mar 2024	£10,301,344	£5,354,237	£937,131	link
Mar 2023	£28,254,992	£11,694,492	£7,154,110	link
Mar 2022	£32,522,939	£15,491,533	£5,778,813	link
Mar 2021	£34,270,948	£20,797,365	£4,505,612	link
Mar 2020	£25,992,907	£9,959,119	£5,742,876	link
Mar 2019	£9,308,693	£2,479,341	£2,520,943	link